ONMD · OneMedNet Corp

OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. It offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets markets. The company also provides BEAM, a medical imaging exchange platform between hospital/healthcare systems, imaging centers, physicians, and patients. OneMedNet Corporation is headquartered in Eden Prairie, Minnesota.

Cap structure and valuation

Cap structure
SP	$0.62
SO	54.4M
Options	0.6M
Warrants	14.3M
FD SO	69.4M
MC	$43.4M

Cash	$0.2M
Total debt	$0.2M
EV	$43.3M

TTM Multiples
EV / Revenue	32.8x
EV / EBITDA	—
MC / Net Income	—
EV / FCF	—
MC / FCF	—

Ownership & coverage
Institutional	19.1%
Insiders	70.1%
# Institutions	23
Analysts	0
Consensus	—
Avg target	—

Short % float	1.2%
Days to cover	1.06

MC = SP × FD SO. EV = MC + Debt − Cash. SP = previous yfinance close. Balance-sheet figures as of 2026-05-12. Multiples use TTM (sum of last 4 quarters); shown as "—" when the denominator is zero or negative, or when fewer than four quarters are reported — a partial sum is not a trailing twelve months. Ownership & coverage per Yahoo Finance as of 2026-08-10 — institutional % is 13F-based, so it can lag a quarter and exceed 100% on share-count timing. Short interest per FINRA bi-monthly reporting, as of 2026-07-15; the float denominator can be unreliable on tiny floats.

Financial statements

	3/31/26	12/31/25	9/30/25	6/30/25
Total Revenue	0.10	0.89	0.18	0.15
Revenue YoY %	(29.9%)	3326.9%	24.6%	(31.7%)
Cost of Revenue	0.48	0.73	0.40	0.40
Gross Profit	(0.38)	0.17	(0.22)	(0.24)
Gross Profit YoY %	(69.6%)	734.6%	(164.3%)	(136.3%)
Gross Margin %	(395.8%)	18.5%	(125.4%)	(155.5%)

SG&A	1.86	2.80	1.69	1.44
R&D	0.31	0.44	0.32	0.38
Operating Expense	2.17	3.25	2.01	1.82

Operating Income	(2.55)	(3.08)	(2.23)	(2.06)
Operating Income YoY %	(140.3%)	(13.5%)	4.3%	15.9%
Operating Margin %	(2658.3%)	(345.9%)	(1262.7%)	(1331.0%)
EBITDA	(2.54)	(3.07)	(2.23)	(2.03)
EBITDA Margin %	(2646.9%)	(344.9%)	(1257.1%)	(1309.0%)

Interest Expense	0.01	0.01	0.01	0.02
Other Income / (Expense)	—	—	1.50	5.07
Pretax Income	(2.45)	(3.14)	(0.74)	2.98
Net Income	(2.45)	(3.14)	(0.74)	2.98
Net Margin %	(2555.2%)	(352.4%)	(418.6%)	1923.9%

Diluted EPS	-$0.04	-$0.07	-$0.01	$0.07
Basic EPS	-$0.04	-$0.07	-$0.01	$0.07
Diluted Avg Shares	55.3	—	52.6	38.4
Basic Avg Shares	55.3	—	52.6	36.8

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Total Revenue	1.32	1.36	0.64	1.02	1.15
Revenue YoY %	(2.9%)	111.4%	(37.0%)	(11.4%)	—
Cost of Revenue	2.00	1.86	0.92	1.15	1.51
Gross Profit	(0.68)	(0.50)	(0.28)	(0.13)	(0.36)
Gross Profit YoY %	(34.8%)	(79.0%)	(117.8%)	64.2%	—
Gross Margin %	(51.4%)	(37.0%)	(43.7%)	(12.6%)	(31.2%)

SG&A	7.79	7.65	7.86	4.66	5.76
R&D	1.46	1.51	1.47	2.06	1.59
Operating Expense	9.25	9.16	9.32	6.72	7.36

Operating Income	(9.93)	(9.67)	(9.61)	(6.85)	(7.71)
Operating Income YoY %	(2.7%)	(0.6%)	(40.2%)	11.2%	—
Operating Margin %	(753.0%)	(711.3%)	(1493.8%)	(671.2%)	(669.1%)
EBITDA	(9.87)	(9.60)	(9.55)	(6.83)	(7.69)
EBITDA Margin %	(748.1%)	(706.5%)	(1484.9%)	(668.5%)	(667.0%)

Interest Expense	0.05	0.07	0.15	0.01	0.40
Other Income / (Expense)	6.63	6.93	—	(26.90)	8.47
Pretax Income	(3.35)	(2.80)	(10.13)	(33.76)	0.35
Tax Provision	—	0.00	0.00	0.02	0.02
Net Income	(3.35)	(2.80)	(10.13)	(33.78)	0.34
Net Income to Common	(3.35)	(2.80)	(10.13)	(33.78)	(30.45)
Net Margin %	(254.1%)	(206.1%)	(1575.3%)	(3308.5%)	29.2%

Diluted EPS	-$0.05	-$0.06	-$0.36	-$4.65	-$7.66
Basic EPS	-$0.05	-$0.06	-$0.36	-$4.65	-$7.66
Diluted Avg Shares	55.3	44.5	28.1	7.3	4.0
Basic Avg Shares	55.3	44.5	28.1	7.3	4.0

	3/31/26	12/31/25	9/30/25	6/30/25
Cash & Equivalents	0.23	0.58	0.15	0.12
Receivables	0.70	0.49	0.58	0.25
Other Current Assets	0.53	1.01	0.71	1.89
Total Current Assets	1.46	2.10	1.45	2.27

Net PPE	0.05	0.06	0.06	0.07
Total Assets	1.51	2.15	1.51	2.34

Current Debt	0.84	0.97	—	—
Other Current Liabilities	4.52	3.85	5.00	6.16
Total Current Liabilities	5.36	4.83	5.00	6.16
Long-term Debt	0.18	0.22	—	—
Total Liabilities	5.59	5.12	5.45	6.18
Mezzanine Equity	—	—	—	2.60

Retained Earnings	(106.82)	(104.37)	(101.23)	(100.49)
Total Equity	(4.08)	(2.96)	(3.94)	(6.44)

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Cash & Equivalents	0.23	0.58	0.17	0.05	0.27
Receivables	0.70	0.49	0.21	0.15	0.02
Other Current Assets	0.53	1.01	3.23	—	—
Total Current Assets	1.46	2.10	3.62	0.36	0.39

Net PPE	0.05	0.06	0.11	0.10	0.08
Other Assets	—	—	—	—	0.81
Total Assets	1.51	2.15	3.73	0.46	1.29

Current Debt	0.84	0.97	9.38	—	—
Other Current Liabilities	4.52	3.85	9.85	13.84	26.10
Total Current Liabilities	5.36	4.83	19.23	13.84	26.10
Long-term Debt	0.18	0.22	—	0.47	—
Other Liabilities	—	—	—	—	1.54
Total Liabilities	5.59	5.12	19.68	13.91	27.65
Mezzanine Equity	—	—	—	—	17.64

Retained Earnings	(106.82)	(104.37)	(101.57)	(91.44)	(57.66)
Total Equity	(4.08)	(2.96)	(15.95)	(13.44)	(44.00)

	3/31/26	12/31/25	9/30/25	6/30/25
Net Income	(2.45)	(3.14)	(0.74)	2.98
D&A	0.01	0.01	0.01	0.03
Stock-Based Comp	0.43	1.49	0.14	0.20
Δ Working Cap & Other	0.47	(0.07)	(0.97)	(5.50)
Operating Cash Flow	(1.54)	(1.71)	(1.56)	(2.28)

CapEx	(0.00)	(0.01)	0.00	(0.00)
Other Investing	—	—	1.11	(0.67)
Investing Cash Flow	0.35	(0.05)	1.11	(0.67)

Stock Issuance	—	—	0.50	—
Other Financing	0.84	2.20	—	3.03
Financing Cash Flow	0.84	2.20	0.48	3.03

Free Cash Flow	(1.54)	(1.72)	(1.56)	(2.29)

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Net Income	(3.35)	(2.80)	(10.13)	(33.78)	0.34
D&A	0.06	0.07	0.06	0.03	0.03
Stock-Based Comp	2.25	2.03	0.63	1.48	1.86
Δ Working Cap & Other	(6.06)	(6.80)	2.46	27.49	(6.93)
Operating Cash Flow	(7.10)	(7.50)	(6.98)	(4.79)	(4.70)

CapEx	(0.01)	(0.01)	(0.05)	(0.04)	(0.06)
Other Investing	0.75	2.32	(1.93)	—	—
Investing Cash Flow	0.74	2.31	(1.98)	(0.04)	(0.06)

Debt Repayment	—	—	(0.20)	—	—
Other Financing	6.54	5.61	9.29	4.61	4.33
Financing Cash Flow	6.54	5.61	9.09	4.61	4.33

Free Cash Flow	(7.11)	(7.52)	(7.03)	(4.83)	(4.76)

	3/31/26	12/31/25	9/30/25	6/30/25
Current Ratio	0.27	0.43	0.29	0.37
Quick Ratio	—	—	—	—
Debt / Equity	-1.37	-1.73	-1.38	-0.96
EBITDA Margin %	(2646.9%)	(344.9%)	(1257.1%)	(1309.0%)
Working Capital	(3.90)	(2.73)	(3.56)	(3.89)
Net Debt	(0.06)	(0.36)	—	—
ROE %	60.1%	105.9%	18.8%	(46.3%)
ROA %	(162.8%)	(146.0%)	(49.2%)	127.6%

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Current Ratio	0.27	0.43	0.19	0.03	0.01
Quick Ratio	—	—	—	—	—
Debt / Equity	-1.37	-1.73	-1.23	-1.03	-0.63
EBITDA Margin %	(748.1%)	(706.5%)	(1484.9%)	(668.5%)	(667.0%)
Working Capital	(3.90)	(2.73)	(15.61)	(13.47)	(25.71)
Net Debt	(0.06)	(0.36)	—	0.42	—
ROE %	82.2%	94.5%	63.5%	251.3%	(0.8%)
ROA %	(222.4%)	(130.2%)	(271.8%)	(7280.2%)	26.1%

Insider activity (last 2 years)

Date Filed	Reporter	Relationship	Trans. Date	Code	Shares	Price	Total Value
2026-08-07	Kosasa Thomas	Director, 10% Owner	2026-07-30	P	1,449,275	$0.69	$1,000,000
2026-06-24	Green Aaron	Director, Officer (Chief Executive Officer)	2026-06-23	P	36,650	$0.57	$21,011
2026-06-24	Yu Jeffrey	Director, Officer (Chief Medical Officer), 10% Owner	2026-06-23	P	158,730	$0.63	$100,000
2026-06-17	Yu Jeffrey	Director, Officer (Chief Medical Officer), 10% Owner	2026-06-16	P	172,414	$0.58	$100,000
2026-06-16	Green Aaron	Director, Officer (Chief Executive Officer)	2026-06-15	P	18,702	$0.54	$10,092
2026-06-16	Green Aaron	Director, Officer (Chief Executive Officer)	2026-06-12	P	36,920	$0.56	$20,605
2026-06-15	Kosasa Thomas	Director, 10% Owner	2026-06-12	P	158,730	$0.63	$100,000
2026-05-20	Kosasa Thomas	Director, 10% Owner	2026-05-18	P	268,817	$0.93	$250,000
2026-04-24	Kosasa Thomas	Director, 10% Owner	2026-04-23	P	280,898	$0.89	$249,999
2026-04-24	Yu Jeffrey	Director, Officer (Chief Medical Officer), 10% Owner	2026-04-01	P	903,614	$0.83	$750,000
2026-04-24	Yu Jeffrey	Director, Officer (Chief Medical Officer), 10% Owner	2026-04-01	A	219,429	$0.83	$182,126
2026-04-24	Kosasa Thomas	Director, 10% Owner	2026-02-06	P	595,238	$0.84	$500,000
2025-12-23	Green Aaron	Director, Officer (Chief Executive Officer)	2025-11-18	S	(61,555)	$1.20	-$73,903
2025-12-23	Green Aaron	Director, Officer (Chief Executive Officer)	2025-10-22	S	(64,767)	$2.23	-$144,722
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-11-26	A	45,000	—	$0
2025-11-26	Golden Robert Lawrence	Director, Officer (Chief Financial Officer)	2025-11-26	A	45,000	—	$0
2025-11-26	Green Aaron	Director, Officer (Chief Executive Officer)	2025-11-26	A	45,000	—	$0
2025-11-26	McCraw Sherry Coonse	Director	2025-11-26	A	45,000	—	$0
2025-11-26	Kosasa Thomas	Director	2025-11-26	A	45,000	—	$0
2025-11-26	Clarke Jair	Director	2025-11-26	A	45,000	—	$0
2025-11-26	Zeinfeld Andrew B	Director	2025-11-26	A	45,000	—	$0
2025-11-26	Casaburi Eric	Director	2025-11-26	A	45,000	—	$0
2025-11-26	Alleyne Kenneth	Director	2025-11-26	A	38,219	—	$0
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-11-24	A	200,000	—	$0
2025-11-26	Golden Robert Lawrence	Director, Officer (Chief Financial Officer)	2025-11-24	A	300,000	—	$0
2025-11-26	Golden Robert Lawrence	Director, Officer (Chief Financial Officer)	2025-11-24	A	33,333	—	$0
2025-11-26	Green Aaron	Director, Officer (Chief Executive Officer)	2025-11-24	A	1,000,000	—	$0
2025-11-26	Casaburi Eric	Director	2025-10-15	P	10,000	$3.05	$30,500
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-09-25	P	1,250	$1.03	$1,288
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-09-24	P	17,200	$1.02	$17,544
2025-11-26	Kosasa Thomas	Director	2025-09-24	P	6,000	$0.93	$5,599
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-09-23	P	5,700	$0.93	$5,301
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-09-22	P	400	$0.95	$380
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-09-19	P	1,250	$0.89	$1,112
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-09-18	P	700	$0.91	$637
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-09-05	P	2,100	$0.86	$1,806
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-09-04	P	11,810	$0.87	$10,275
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-09-03	P	11,670	$0.81	$9,453
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-09-02	P	24,319	$0.85	$20,671
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-08-29	P	10,890	$0.82	$8,930
2025-11-26	Kosasa Thomas	Director	2025-08-29	P	581,395	$0.86	$500,000
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-08-28	P	17,000	$0.80	$13,600
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-08-27	P	21,374	$0.69	$14,748
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-08-26	P	173,350	$0.69	$119,611
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-08-25	P	13,300	$0.75	$9,975
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-08-21	P	15,000	$0.77	$11,550
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-08-19	P	16,500	$0.77	$12,705
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-06-20	P	1,666,666	$0.42	$700,000
2025-11-26	Kosasa Thomas	Director	2025-06-20	P	1,190,476	$0.42	$500,000
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-06-19	C	1,828,279	$0.71	$1,298,078
2025-11-26	Kosasa Thomas	Director	2025-06-19	C	2,123,424	$0.75	$1,598,938
2025-11-26	Kosasa Thomas	Director	2025-06-19	C	2,865,016	$0.71	$2,034,161
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-06-17	C	479,270	$1.14	$546,368
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-06-17	C	(479,270)	$1.14	-$546,368
2025-11-26	Green Aaron	Director, Officer (Chief Executive Officer)	2025-06-17	C	240,425	$1.14	$274,084
2025-11-26	Green Aaron	Director, Officer (Chief Executive Officer)	2025-06-17	C	(240,425)	—	$-0
2025-11-26	Kosasa Thomas	Director	2025-06-17	C	493,056	$1.14	$562,084
2025-11-26	Kosasa Thomas	Director	2025-06-17	C	(493,056)	—	$-0
2025-11-26	Kosasa Thomas	Director	2025-06-16	P	55,000	$0.38	$21,016
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2025-05-09	P	5,946	$0.03	$178
2025-11-26	Kosasa Thomas	Director	2025-04-21	P	47,000	$0.49	$22,861
2025-11-26	Golden Robert Lawrence	Director, Officer (Chief Financial Officer)	2025-01-31	A	24,272	—	$0
2025-11-26	Clarke Jair	Director	2025-01-01	A	82,143	—	$0
2025-11-26	Zeinfeld Andrew B	Director	2025-01-01	A	82,143	—	$0
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-12-18	P	100	$0.99	$99
2025-11-26	Casaburi Eric	Director	2024-11-20	P	1,300	$0.87	$1,131
2025-11-26	Casaburi Eric	Director	2024-11-12	P	500	$0.85	$425
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-10-01	A	230,769	$0.57	$131,538
2025-11-26	McCraw Sherry Coonse	Director	2024-10-01	A	11,342	—	$0
2025-11-26	Clarke Jair	Director	2024-10-01	A	11,342	—	$0
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-09-20	P	1,600	$0.66	$1,056
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-09-18	P	800	$0.68	$544
2025-11-26	Golden Robert Lawrence	Director, Officer (Chief Financial Officer)	2024-08-30	A	100,000	—	$0
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-08-21	P	100	$1.22	$122
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-08-16	P	14	$1.41	$20
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-08-15	P	10	$1.34	$13
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-08-14	P	13	$1.35	$18
2025-11-26	Zeinfeld Andrew B	Director	2024-08-14	A	17,260	—	$0
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-08-13	P	2,237	$1.19	$2,662
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-08-12	P	913	$1.10	$1,004
2025-11-26	Casaburi Eric	Director	2024-07-08	P	4,100	$0.92	$3,772
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-05-10	P	1,203	$0.52	$626
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-05-08	P	105	$0.69	$72
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-05-07	P	106	$0.68	$72
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-05-06	P	214	$0.65	$139
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-05-03	P	350	$0.60	$210
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-05-02	P	100	$0.62	$62
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-04-24	P	100	$0.65	$65
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-03-22	P	100	$0.79	$79
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-03-06	P	16	$0.84	$13
2025-11-26	Casaburi Eric	Director	2024-03-05	P	2,000	$0.74	$1,480
2025-11-26	Casaburi Eric	Director	2024-02-29	P	575	$0.72	$414
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-02-16	P	100	$0.82	$82
2025-11-26	Casaburi Eric	Director	2024-02-16	P	2,000	$0.77	$1,540
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-02-08	P	2	$1.19	$2
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-02-01	P	1,357	$1.45	$1,968
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-30	P	400	$1.14	$456
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-29	P	950	$1.04	$988
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-26	P	5,386	$0.56	$3,016
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-25	P	2,304	$0.55	$1,267
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-24	P	740	$0.55	$407
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-23	P	720	$0.52	$374
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-22	P	5,035	$0.49	$2,467
2025-11-26	Golden Robert Lawrence	Director, Officer (Chief Financial Officer)	2024-01-19	A	45,000	—	$0
2025-11-26	Green Aaron	Director, Officer (Chief Executive Officer)	2024-01-19	A	45,000	—	$0
2025-11-26	Kosasa Thomas	Director	2024-01-19	A	45,000	—	$0
2025-11-26	Casaburi Eric	Director	2024-01-19	A	45,000	—	$0
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-19	P	60	$0.48	$29
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-19	A	45,000	—	$0
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-17	P	362	$0.61	$221
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-16	P	15	$0.75	$11
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-12	P	20	$0.81	$16
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-10	P	20	$0.85	$17
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-09	P	100	$0.86	$86
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-08	P	10	$0.83	$8
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-04	P	180	$0.84	$151
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2024-01-02	P	20	$0.82	$16
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2023-12-27	P	10	$1.03	$10
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2023-12-15	P	10	$0.92	$9
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2023-12-13	P	50	$1.09	$55
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2023-12-12	P	3,040	$1.06	$3,222
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2023-12-11	P	30	$1.36	$41
2025-11-26	Yu Jeffrey	Director, Officer (Chief Medical Officer)	2023-12-08	P	3,300	$1.31	$4,323
2025-11-26	Golden Robert Lawrence	Director, Officer (Chief Financial Officer)	2023-12-07	P	300	$1.71	$513